Conclusion: There is insufficient evidence to either support or refute the use of acupuncture (either needle or laser) in the treatment of lateral elbow pain. This review has demonstrated needle acupuncture to be of short term benefit with respect to pain, but this finding is based on the results of 2 small trials, the results of which were not able to be combined in meta-analysis. No benefit lasting more than 24 hours following treatment has been demonstrated. No trial assessed or commented on potential adverse effect. Further trials, utilising appropriate methods and adequate sample sizes, are needed be
PubMed 11869671 ↗Vitamin B12 Injection
The short answer. There isn't much data on Vitamin B12 Injection yet — 3 mentions, 2 with a clear outcome — so treat these numbers as anecdotal. There is a moderate body of research — 1 meta-analyses and 3 trials.
Out of 3 mentions; the other 33% didn't say how it went and aren't counted.
What Vitamin B12 Injection does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found.
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“It did give me some energy and increased mood. The pill form is extremely inefficient compared to injection.”
“Worst subq injection I can think of would be shooting 1ml of that dark red B12. That hurts like a bee sting.”
Other options for mood
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 3, 2026. How we rate